Parsing an enigma: the pharmacodynamics of aspirin resistance

This publication has 14 references indexed in Scilit:

• COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
  Proceedings of the National Academy of Sciences, 2002
• Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
  BMJ, 2002
• Nonselective nonaspirin nonsteroidal antiinflammatory medications are associated with reduced risk of myocardial infarction
  Journal of the American College of Cardiology, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study
  The Lancet, 2002
• Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
  New England Journal of Medicine, 2001
• The Coxibs, Selective Inhibitors of Cyclooxygenase-2
  New England Journal of Medicine, 2001
• Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
  Journal of Clinical Investigation, 1983
• Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
  Journal of Clinical Investigation, 1982
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
  Proceedings of the National Academy of Sciences, 1975